ES16001

· Genencell Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ES16001, covering 2023-02-22 to 2023-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of ES16001 in Patients With COVID-19 [Phase 2, Phase 3]